CAMBRIDGE UNIVERSITY UK Robinson College – Faculty of Law 23rd Annual Fordham Conference Intellectual Property Law and Policy 8 – 9 April 2015 Patent Session.

Slides:



Advertisements
Similar presentations
Technology Center 1600 Training on Writing Rejections Under 35 U.S.C. § 103.
Advertisements

Intellectual Property Fundamentals Ed Genocchio - Principal of Spruson & Ferguson - Mechanical Group Presentation to The Australian Technology Showcase.
No longer business as usual Patent-eligibility of “business methods” Nicholas Milne Senior Associate Baxter IP.
Utility and Written Description Steve Kunin Deputy Commissioner for Patent Examination Policy Esther Kepplinger Deputy Commissioner for Patent Operations.
Recent Cases on Patentable Subject Matter and Patent Exhaustion Mojdeh Bahar, J.D., M.A. Chief, Cancer Branch Office of Technology Transfer National Institutes.
Industrial Property the Patent system
Diagnostics: Patent Eligibility and the Industry Perspective
1 Bioinformatics Practice Considerations October 20, 2011 Ling Zhong, Ph.D.
PATENTABLE SUBJECTS IN THE INTERNET OF THINGS ALICIA SHAH.
© Cambridge International Examinations 2013 Component/Paper 1.
The America Invents Act (AIA) - Rules and Implications of First to File, Prior Art, and Non-obviousness -
Invention Spotting – Identifying Patentable Inventions Martin Vinsome June 2012.
AIPLA Biotechnology Committee Webinar: Mayo v. Prometheus: Did the Bell Toll for Personalized Medicine Patents? Prof. Joshua D. Sarnoff DePaul U. College.
“REACH-THROUGH CLAIMS”
1 Biotechnology Partnership Meeting April 17, 2001 James Martinell Senior Level Examiner Technology Center 1600.
Intellectual Property March 4, 2015 Don Keach Director, Intellectual Property Development and Technology Transfer Office Copyright University of Kentucky.
Drugs which are not patentable
Patents Copyright © Jeffrey Pittman. Pittman - Cyberlaw & E- Commerce 2 Legal Framework of Patents The U.S. Constitution, Article 1, Section 8:
Biopiracy Biopiracy is defined as, “the illegal appropriation of life – micro-organisms, plants and animals (including humans) and the traditional knowledge.
Intellectual Property Boston College Law School February 12, 2007 Patent - Subject Matter.
Intellectual Property Boston College Law School February 11, 2009 Patent - Subject Matter, Utility.
Intellectual Property Boston College Law School March 3, 2008 Patent - Nonobviousness.
Patents 101 April 1, 2002 And now, for something new, useful and not obvious.
Intellectual Property Boston College Law School February 16, 2009 Patent – Novelty.
® ® From Invention to Start-Up Seminar Series University of Washington The Legal Side of Things Invention Protection Gary S. Kindness Christensen O’Connor.
Patentable Subject Matter and Design Patents,Trademarks, and Copyrights David L. Hecht, J.D., M.B.A, B.S.E.E.
1 Unity of Invention: Biotech Examples TC1600 Special Program Examiner Julie Burke (571)
Utility Requirement in Japan Makoto Ono, Ph.D. Anderson, Mori & Tomotsune Website:
MSE602 ENGINEERING INNOVATION MANAGEMENT
Genetic advances will only be acceptable if their application is carried out ethically, with due regard to autonomy, justice, education and the beliefs.
Professor Peng  Patent Act (2008) ◦ Promulgated in 1984 ◦ Amended in 1992, 2000, and 2008.
Impact of Myriad Decisions on Patent Eligibility of Biotechnology Inventions in Australia and the US.
© 2011 Barnes & Thornburg LLP. All Rights Reserved. This page, and all information on it, is the property of Barnes & Thornburg LLP which may not be reproduced,
Internal Control in a Financial Statement Audit
Cambridge Pre-U Getting Started In-service Training Liberating learning Developing successful students.
Josiah Hernandez Patentability Requirements. Useful Having utilitarian or commercial value Novel No one else has done it before If someone has done it.
1 Written Description Analysis and Capon v. Eshhar Jeffrey Siew Supervisory Patent Examiner AU 1645 USPTO (571)
Intellectual Property Law © 2007 IBM Corporation EUPACO 2 – The European Patent Conference 16 May 2007 Patent Quality Roger Burt IBM Europe.
Hamre, Schumann, Mueller & Larson, P.C U.S. Patent Claims By James A. Larson.
Patentability Considerations in the 3-D Structure Arts Patentability Considerations in the 3-D Structure Arts Michael P. Woodward Supervisory Patent Examiner.
Overview Validity of patent hinges on novelty, utility, and non-obviousness Utility generally not an issue Pre-suit investigation focuses on infringement,
Trilateral Project WM4 Report on comparative study on Examination Practice Relating to Single Nucleotide Polymorphisms (SNPs) and Haplotypes. Linda S.
The Subject Matter of Patents II Class Notes: April 8, 2003 Law 677 | Patent Law | Spring 2003 Professor Wagner.
Data Governance Patents, Security and Privacy Duke University, November 9, 2015 Ryan Vinelli.
Examination Practice in Applications Presenting “Reach-Through Claims” George Elliott Practice Specialist Technology Center 1600
Mayo v. Prometheus Labs – The Backdrop June 12, 2012 © 2012, all rights reserved.
© 2008 International Intellectual Property June 16, 2009 Class 2 Introduction to Patents.
1 Patent Claim Interpretation under Art. 69 EPC – Should prosecution history be used to interpret the patent? presented at Fordham 19th Annual Conference.
Myriad The Future of DNA Claims Mercedes Meyer, Ph.D., JD AIPLA 1.
Introduction The Patentability of Human Genes Is patenting human genes moral? Should it be legal? Should there be international intervention?
Class 24: Finish Remedies, then Subject Matter Patent Law Spring 2007 Professor Petherbridge.
The Relationship Between Intellectual Property Rights Abuse and Monopoly Wang Xianlin, KoGuan Law School of Shanghai Jiao Tong University Dalian, June.
McGraw-Hill/Irwin © The McGraw-Hill Companies 2010 Internal Control in a Financial Statement Audit Chapter Six.
AUDIT STAFF TRAINING WORKSHOP 13 TH – 14 TH NOVEMBER 2014, HILTON HOTEL NAIROBI AUDIT PLANNING 1.
Patents 101 March 28, 2006 And now, for something new, useful and not obvious.
Jody Blanke, Professor Computer Information Systems and Law 1.
Patents 101 March 28, 2006 And now, for something new, useful and not obvious.
Tech Mahindra Limited v Commissioner of Taxation
The Challenge of Biotech Patent Eligibility in the United States:
Alexandria, Virginia July 21, 2014
PATENTS IT.CAN Annual Meeting
Introduction Intellectual property includes the application of property in the areas of trade secrets, patents, trademarks, and copyrights.
Au - Business Methods Expansion of the Internet and e-commerce led to many patents being applied for and granted for “business methods”. Business Method.
INTELLECTUAL PROPERTY MANAGEMENT
ChIPs Global Summit, September 15, 2016
Patentability of AI related inventions
Global Innovation Management Workout on Writing a Patent
Patents II Disclosure Requirements
A tutorial and update on patentable subject matter
Presentation transcript:

CAMBRIDGE UNIVERSITY UK Robinson College – Faculty of Law 23rd Annual Fordham Conference Intellectual Property Law and Policy 8 – 9 April 2015 Patent Session 8C Patentable Subject Matter The Hon Justice Annabelle Bennett AO Judge of the Federal Court of Australia

 Isolated nucleic acid  Computer implementation of a business scheme  Touchscreen patents

D’ARCY v MYRIAD GENETICS INC [2014] FCAFC 15 Claim 1 An isolated nucleic acid coding for a mutant or polymorphic BRCA1 polypeptide, said nucleic acid containing in comparison to the BRCA1 polypeptide encoding sequence set forth in SEQ.ID No:1 one or more mutations or polymorphisms selected from the mutations set forth in Tables 12, 12A and 14, and the polymorphisms set forth in Tables 18 and 19.

[T]he view which we think is correct in the present case is that the method the subject of the relevant claims has at its end result an artificial effect falling squarely within the true concept of what must be produced by a process if it is to be held patentable.

… the distinction between discovery and invention is not precise enough to be other than misleading in this area of discussion. There may indeed be a discovery without invention – either because the discovery is some piece of abstract information without any suggestion of a practical application of it to a useful end, or because its application lies outside the realm of ‘manufacture’.

… it confuses the issue to use such terms as “the work of nature” and the “laws of nature”. It is not decisive or helpful to point out that the suggestion is that nature, in its newly ascertained aspect, be allowed to work in its own way. Expressions such as the “work of nature” or the “laws of nature” could fairly be employed to challenge almost any patent.

The reason [Novelty] is manifest, because much further information, and therefore much further discovery, are required before the real truth can be extricated and embodied in a form to serve the use of mankind. It is the difference between the ore and the refined and pure metal which is extracted from it… The prior knowledge of an invention to avoid a patent must be knowledge equal to that required to be given by a specification, namely, such knowledge as will enable the public to perceive the very discovery, and to carry the invention into practical use. [emphasis added] (Hill v Evans)

… ‘if a process which does not produce a new substance but nevertheless results in “a new and useful effect”’, so that the new result is ‘an artificially created state of affairs providing economic utility, it may be considered a “manner of new manufacture”’ within s 6 of the Statute of Monopolies

… Patent monopolies are as much an appropriate reward for research into hitherto unknown therapeutic uses of (known) compounds, which uses benefit mankind, as they are for research directed to novel substances or compounds for therapeutic use in humans. It is not possible to erect a distinction between such research based on public policy considerations.

“What is being claimed is not the nucleic acid as it exists in the human body but the nucleic acid as isolated from the cell. The claimed product is not the same as the naturally occurring product”.

RESEARCH AFFILIATES LLV v COMMISSIONER OF PATENTS Claim 1 A computer-implemented method for generating an index, the method including steps of: (a)accessing data relating to a plurality of assets; (b)processing the data thereby to identify a selection of the assets for inclusion in the index based on an objective measure of scale other than share price, market capitalization and any combination thereof; (c)accessing a weighting function configured to weight the selected assets; (d)applying the weighting function, thereby to assign to each of the selected assets a respective weighting, wherein the weighting: i.is based on an objective measure of scale other than share price, market capitalization and any combination thereof; and ii.is not based on market capitalization weighting, equal weighting, share price weighting and any combination thereof; thereby to generate the index.

Although the summary of the invention and the exemplary embodiments do make reference to computers, it is to be noted that what is missing from the title of the invention, the described field of the invention and the detailed description of the invention is any reference to a computer, even though the claims limit the method of the invention to one that is computer- implemented.

Description of exemplary embodiment: “an analyst may use a computer system to generate an index”.

The only claims to a computer system, rather than to a method, are claim 26, being to a computer system configured to perform a method according to any of claims 1 to 25, and claim 28 which is to a computer system including the means for carrying out the steps of the method.

Court considered: UK  IBM  Symbiom  Aerotel  HTC US  Bilski  Alice Corporation

Turning to the present appeal, the relevant inquiry is not into the form of the words to determine whether what is claimed is properly the subject of a patent. If a process is to be patentable, it must offer some advantage which is material, in the sense that the process belongs to a useful art. The characterisation of patentability by reference only to the description in NRDC of a product which consists of an artificially created state of affairs of economic significance was part of the High Court’s reasoning but did not represent a sufficient or exhaustive statement of the circumstances in which a claimed invention is patentable.

The determination whether the claimed invention is truly “an artificially created state of affairs” in satisfaction of NRDC is made not by some mechanistic application of the criterion of artificiality or physical effect, but by an understanding of the claimed invention itself. The invention is to be understood as a matter of substance and not merely as a matter of form.

The invention set out in the specification is directed to the index itself. The method of the invention is not one that has any artificial or patentable effect other than the implementation of a scheme, which happens to use a computer to effect that implementation… In the context of the claim, the significance lies in the content of the data rather than any specific effect generated by the computer.

APPLE v SAMSUNG  Touchscreen Patents

* * *